Homografts, Contegra, and Hancock conduits showed no significant difference in 5-year freedom from conduit exchange (69.4%, 59.4%, and 53.8%, respectively; P=0.4) in infants.
Cohort (n=145)
Does the type of conduit (homograft, Contegra, or Hancock) affect freedom from conduit exchange, stenosis, or insufficiency in patients below 1 year of age requiring RVOT reconstruction?
Homografts, bovine jugular vein conduits, and porcine-valved Dacron conduits exhibit equal durability for RVOT reconstruction in infants, though Contegra conduits may develop stenosis or insufficiency earlier.
p-value: p=0.4
OBJECTIVES: Reconstruction of the right ventricular outflow tract (RVOT) with a conduit in patients below 1 year of age remains a matter of concern due to limited availability and durability of conduits. We sought to analyse the freedom from conduit exchange in this subgroup of patients by comparing different conduits. METHODS: Data of 145 consecutive patients below 1 year of age, requiring a conduit for RVOT reconstruction between 1994 and 2011 were reviewed. The endpoints of the study were defined as: 'conduit exchange for any reason', 'at least moderate conduit stenosis' and 'at least moderate insufficiency'. RESULTS: Homografts, bovine jugular vein conduits (Contegra) and porcine-valved Dacron conduits (Hancock) were implanted in 62 (43%), 35 (24%) and 48 (33%) patients, respectively. The mean conduit diameter was 12.9 ± 1.3 mm. A conduit exchange was necessary in 72 patients (55%) at a median time of 5.9 years 1.1-10.8. The rate of freedom from conduit exchange at 5 years was 69.4 ± 6.6, 59.4 ± 8.7 and 53.8 ± 7.4%, respectively (P = 0.4). The rate of freedom from at least moderate stenosis was 85.4 ± 5.6, 75.1 ± 9.1 69.1 ± 7.9% at 5 years and 59.2 ± 11.1, 35.8 ± 12.0, 49.7 ± 10.1% at 10 years, for homografts, Contegra and Hancock conduits, respectively. The rate of freedom from at least moderate conduit insufficiency was 91.7 ± 4, 74.6 ± 9.1, 86.9 ± 7.4% at 5 years and 64.8 ± 14.1, 44.2 ± 13.7, 52.1 ± 14.2% at 10 years, for homografts, Contegra and Hancock conduits, respectively. Patients with a Contegra conduit developed moderate conduit stenosis or insufficiency faster than patients with a homograft (P = 0.01). Age below 1 month and heterotopic implantation of the conduit emerged as risk factors for conduit exchange in the univariate analysis (P = 0.05, P = 0.02, respectively). There was no significant influence of the conduit type, conduit size, z-score or the body surface area. In the multivariate analysis, heterotopic implantation emerged as the only risk factor for conduit exchange (P = 0.02, hazard ratio = 1.6, 95% confidence interval = 1.0-2.7). CONCLUSIONS: Homografts, bovine jugular vein conduits and porcine-valved Dacron conduits exhibit equal durability after implantation in patients below 1 year of age independent of their size. Nonetheless, moderate conduit stenosis or insufficiency develops earlier in patients with a Contegra conduit. Conduit placement in the neonatal period and implantation in a heterotopic position shortens the durability.
Vitanova et al. (Sun,) conducted a cohort in Right ventricular outflow tract (RVOT) reconstruction (n=145). Conduit type (Homografts, Contegra, Hancock) vs. Compared against each other was evaluated on Freedom from conduit exchange at 5 years (p=0.4). Homografts, Contegra, and Hancock conduits showed no significant difference in 5-year freedom from conduit exchange (69.4%, 59.4%, and 53.8%, respectively; P=0.4) in infants.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: